Century Therapeutics Inc (IPSC) — Defensive Interval Ratio
Century Therapeutics Inc (IPSC) has a Defensive Interval Ratio of 1697 days as of June 2026. Defensive assets of $70.07 Million (cash $-, short-term investments $70.07 Million, receivables $-) cover 1697 days of daily cash needs of $41.28K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Century Therapeutics Inc Defensive Interval Ratio (2019–2025)
This chart shows how Century Therapeutics Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the ratio stands at 1697 days, meaning defensive assets of $70.07 Million can fund 1697 days of operations without new revenue. For the complete balance sheet picture, see Century Therapeutics Inc asset portfolio.
Annual Defensive Interval Ratio for Century Therapeutics Inc (2019–2025)
The table below presents the year-by-year Defensive Interval Ratio for Century Therapeutics Inc from 2019 to 2025, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See IPSC working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1009 days | $55.93 Million | $55.41K/day | $- | $55.26 Million | ▲ +637 days |
| 2024 | 372 days | $132.37 Million | $355.57K/day | $- | $130.85 Million | ▼ -2206 days |
| 2023 | 2579 days | $126.08 Million | $48.89K/day | $- | $125.41 Million | ▼ -261 days |
| 2022 | 2840 days | $232.01 Million | $81.69K/day | $- | $231.23 Million | ▼ -1046 days |
| 2021 | 3886 days | $166.68 Million | $42.89K/day | $- | $166.43 Million | ▲ +2396 days |
| 2020 | 1490 days | $49.45 Million | $33.18K/day | $- | $48.54 Million | ▼ -3093 days |
| 2019 | 4584 days | $37.60 Million | $8.20K/day | $- | $37.48 Million | — |